Abstract
Influenza virus has circulated in the human population and co‐evolved with us for centuries or longer, shaping our immune repertoires through a continuous host–virus arms race. Across individuals, antibodies repeatedly converge on shared solutions for capturing this shape‐shifting virus by precisely targeting conserved sites of vulnerability—sites the virus cannot alter without functional cost—through structural features encoded directly by germline immunoglobulin genes. These recurring public antibodies, termed multi‐donor class antibodies, have been pivotal for understanding human anti‐influenza immunity and in guiding vaccine strategies that may shift the balance of the host–virus arms race. As single‐cell biology, structural biology, and computational approaches mature, previously uncharted areas of our immune repertoires are coming into view. Here, we review the current understanding of the influenza‐specific immune repertoire, focusing on antibodies and multi‐donor antibody classes directed toward antigenic supersites on viral hemagglutinin and neuraminidase—the two major targets of protective antibodies—and discuss how these insights may advance the development of game‐changing influenza vaccines.
Funding Information
  • National Institutes of Health